Genomics

Dataset Information

0

Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia [ChIP-Seq]

ABSTRACT: Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia [ChIP-Seq]

PROVIDER: PRJNA533061 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR8906500.fastq.gz Fastqsanger.gz
SRR8906501.fastq.gz Fastqsanger.gz
SRR8906502.fastq.gz Fastqsanger.gz
SRR8906503.fastq.gz Fastqsanger.gz
SRR8906504.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 8

Similar Datasets

Genomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia
| PRJNA533070 | ENA
Genomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia [RNA-Seq]
| PRJNA533192 | ENA
Transcriptomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia
2019-11-01 | GSE129863 | GEO
Genomics Target BUB1 kinase as a therapeutic strategy for inhibiting STAT3 signal pathway in Bladder cancer
| PRJNA534083 | ENA
Transcriptomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia [RNA-Seq]
2019-11-01 | GSE129862 | GEO
Genomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia [ChIP-Seq]
2019-11-01 | GSE129861 | GEO
Genomics Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis via SYK activation
| PRJNA608435 | ENA
Genomics Wnt activation as a therapeutic strategy in medulloblastoma
| PRJNA543788 | ENA
Genomics Stimulation of fracture mineralization by salt-inducible kinase inhibitors
| PRJNA1105911 | ENA
Genomics Protectin DX as a therapeutic strategy against frailty in mice
| PRJNA952121 | ENA